跳至主要内容
临床试验/NL-OMON32089
NL-OMON32089已完成不适用

Action Plan to enhance self-management and early detection of exacerbations in patients with COPD; a Randomized Controlled Trial - ACZiE

niversitair Medisch Centrum Utrecht0 个研究点目标入组 180 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
180

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • - Diagnosis of COPD based on post-bronchodilatator FEV1 according to the GOLD
  • standards (=NHG standard).
  • - Diagnosis of COPD as the major functionally limiting disease.
  • - Current use of bronchodilator therapy.

排除标准

  • - Primary diagnosis of asthma (onset < 35 years, >= 12 % postbronchodilator
  • reversibility in FEV1)
  • - Primary diagnosis of cardiac disease
  • - Primary diagnosis of other functionally limiting disease, that could significantly
  • affect either patient mortality (e.g. malignant neoplasm) or participation in the
  • study (e.g. confusional states, psychoses)

研究者

发起方
niversitair Medisch Centrum Utrecht

相似试验

Action Plan to enhance self-management and early... | 临床试验